Skip to main content
Fig. 5 | BMC Ophthalmology

Fig. 5

From: Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes

Fig. 5

A 54-year-old woman with CNV in both eyes was diagnosed. (A) Baseline retinography of CNV diagnosed in the right eye. Baseline BCVA of 20/2000, -16D. (B) Twelve months after anti-VEGF treatment, patchy atrophy progression was detected. (C) Twenty-four months after anti-VEGF treatment, the area of patchy atrophy increased. A final BCVA of 20/67. (D) Baseline retinography of CNV diagnosed in the left eye. Baseline BCVA of 20/67, -17 D. (E) Twelve months after anti-VEGF followed by PSR treatment. (F) Twenty-four months after treatment, no patchy atrophy was detected around the CNV. A final BCVA of 20/50

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us